Comparison of mechanisms and transferability of outcomes of SGLT2 inhibition between type 1 and type 2 diabetes

Diabetes mellitus (DM) is a major chronic disease with ever‐increasing prevalence and a variety of serious complications for persons with DM, such as cardiovascular and/or renal complications. New glucose‐lowering therapies like DPP‐4 inhibitors, GLP‐1 receptor agonists, and SGLT‐2 inhibitors have u...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnell, Oliver, Valensi, Paul, Standl, Eberhard, Ceriello, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375088/
https://www.ncbi.nlm.nih.gov/pubmed/32704554
http://dx.doi.org/10.1002/edm2.129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375088/
https://www.ncbi.nlm.nih.gov/pubmed/32704554
http://dx.doi.org/10.1002/edm2.129

Ejemplares similares